Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rocket Doctor AI ( (TSE:AIDR) ) has issued an update.
Rocket Doctor AI has signed a new in-network agreement with a major commercial insurer in California, extending digital access to its network of board-certified physicians to approximately 175,000 additional members and lifting its total in-network reach to more than 13 million covered lives across key U.S. markets. The deal deepens the company’s presence in one of the country’s largest healthcare markets, strengthens its payer mix across employer-sponsored plans, and is expected to support sustained revenue growth as employers and health plans increasingly seek digital-first, clinician-led care solutions that improve access and reduce friction for members, including those in underserved and remote communities.
The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.79 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.
Spark’s Take on TSE:AIDR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.
The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.
To see Spark’s full report on TSE:AIDR stock, click here.
More about Rocket Doctor AI
Rocket Doctor AI Inc. is a digital health company that delivers physician-built, AI-powered solutions aimed at making high-quality healthcare accessible across the patient journey. Its core technology includes the Global Library of Medicine, a clinically validated decision support system developed with input from hundreds of physicians, and Rocket Doctor Inc., an AI-powered digital health platform and marketplace that enables more than 300 doctors to independently run virtual or hybrid practices. Having supported over 700,000 patient visits, the company focuses on improving clinical efficiency, restoring physician autonomy, and expanding access to care for underserved, rural, and remote communities in Canada as well as Medicaid and Medicare patients in the United States.
Average Trading Volume: 216,687
Technical Sentiment Signal: Buy
Current Market Cap: C$63.73M
See more data about AIDR stock on TipRanks’ Stock Analysis page.